Concepedia

Carmelita Marcantoni

CM

Statistics

Publications

21

Citations

2.2K

H-Index

18

Active since

2000

Affiliations

Ospedale Cannizzaro(Current)

University of Catania

Vanderbilt University Medical Center

University of Bari Aldo Moro

University of Verona

Carmelita Marcantoni is an author at Ospedale Cannizzaro specializing in medicine, nephrology, and chronic kidney disease.

Top concepts

Publications per year

2000–2023

21

Publications

21

Proteinuria as a modifiable risk factor for the progression of non-diabetic renal disease

Tazeen H. Jafar, Paul C. Stark, Christopher H. Schmid et al. · Kidney International · 2001 · 378 citations · Full text

, , +9

Efficacy and safety of sparsentan versus irbesartan in patients with IgA nephropathy (PROTECT): 2-year results from a randomised, active-controlled, phase 3 trial

Brad H. Rovin, Jonathan Barratt, Hiddo J.L. Heerspink et al. · The Lancet · 2023 · 224 citations · Full text

Rituximab or Cyclophosphamide in the Treatment of Membranous Nephropathy: The RI-CYCLO Randomized Trial

Francesco Scolari, Elisa Delbarba, Domenico Santoro et al. · Journal of the American Society of Nephrology · 2021 · 217 citations · Full text

Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active-controlled clinical trial

Hiddo J.L. Heerspink, Jai Radhakrishnan, Charles E. Alpers et al. · The Lancet · 2023 · 203 citations · Full text

, , +9

Peroxisome proliferator-activated receptor-γ agonist troglitazone protects against nondiabetic glomerulosclerosis in rats

Li‐Jun Ma, Carmelita Marcantoni, MacRae F. Linton et al. · Kidney International · 2001 · 192 citations · Full text

, , +11

1–5 of 21